ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/24/2025
Back to search
Official data from USPTO
PRECIGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PRECIGEN
ST13
US500000087366798Class
1, 5, 42, 44, 45
Filing
87366798
Registration
7026015
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
62
Latest update
09/25/2025
Trademark type
Word
Nice classes
1, 5, 42, 44, 45
Filing date
03/10/2017
Registration date
04/11/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/11/2023
Last transaction
09/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2019-04-00
First use in commerce
2019-04-00
Drawing code
4
Owner type
03
Owner location
Blacksburg, VA
Examiner
HUDSON, TAMARA
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PRECIGEN, INC.
PRECIGEN, INC.
I. C. (pessoa física)
Representatives
David R. Kelly Barnes & Thornburg LLP
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicalsbiochemicals and reagents for use in industry and science; chemicalsbiochemicals and reagentsproteins for regulatingmodifying or restricting gene expression; kits consisting primarily of proteins for regulatingmodifying or restricting gene expression
Class 5
Chemical preparations for medical and veterinary purposesfor gene and cell therapy for treating genetic disorderscancersrare diseasesinfectious diseasescardiovascular and immunological diseases and disorders; biochemical preparations for medical and veterinary purposesfor gene and cell therapy for treating genetic disorderscancersrare diseasesinfectious diseasescardiovascular and immunological diseases and disorders; chemical reagents for medical and veterinary purposesfor gene and cell therapy for treating genetic disorderscancersrare diseasesinfectious diseasescardiovascular and immunological diseases and disorders
Class 42
Scientific research and development services in the field of medicinepharmacologyimmunologybiochemistrycell biologygeneticsmicrobiology and virology; Scientific research in the field of healthcare; Therapeutic research of treatments in the fields of oncologyrare diseasesmetabolic disordersinfectious diseasesophthalmologycardiovascular disease which are under development or have completed development; Development of products being genetic therapiesbiopharmaceuticalseffectors to regulatemodulatecharacterize disease states; Development of tools in the nature of software and biotechnological processes to regulatemodulatecharacterize disease states; Research and development services for others in the field of biotechnologygenetically engineering DNAbiological organismscellsvirusespathogensspecial purpose cells for scientificresearchmedical and laboratory use; Research and development services for others in the fields of genetics and biotechnologygenetically engineering DNAbiological organismscellsvirusespathogensspecial purpose cells for scientificresearchmedical and laboratory use
Class 44
Medical services; Medical servicesgenetic engineeringbiopharmaceuticals and gene therapy services; Healthcare servicestreatment of patients with genetic disorderscancersrare diseasesinfectious diseasescardiovascular and immunological diseases and disorders; Medical servicesproviding medical therapy treatments which are under development or have completed development for patients in the fields of oncologyrare diseasesmetabolic disordersinfectious diseasesophthalmologycardiovascular diseases
Class 45
Technology transfer serviceslicensing of intellectual property
Publications
History of USPTO decisions and trademark events.
62 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/07/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/11/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/11/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/07/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/23/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/23/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/23/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/13/2022
GNRT
NON-FINAL ACTION E-MAILED
12/13/2022
CNRT
SU - NON-FINAL ACTION - WRITTEN
12/13/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/19/2022
IUAF
USE AMENDMENT FILED
10/17/2022
EISU
TEAS STATEMENT OF USE RECEIVED
10/17/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/31/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/31/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/31/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/31/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/31/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/12/2022
EX5G
SOU EXTENSION 5 GRANTED
04/11/2022
EXT5
SOU EXTENSION 5 FILED
04/08/2022
EEXT
SOU TEAS EXTENSION RECEIVED
04/08/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/22/2021
EX4G
SOU EXTENSION 4 GRANTED
10/20/2021
EXT4
SOU EXTENSION 4 FILED
10/20/2021
EEXT
SOU TEAS EXTENSION RECEIVED
10/20/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/22/2021
EX3G
SOU EXTENSION 3 GRANTED
04/20/2021
EXT3
SOU EXTENSION 3 FILED
04/20/2021
EEXT
SOU TEAS EXTENSION RECEIVED
04/20/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/24/2020
EX2G
SOU EXTENSION 2 GRANTED
10/22/2020
EXT2
SOU EXTENSION 2 FILED
10/22/2020
EEXT
SOU TEAS EXTENSION RECEIVED
10/22/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/11/2020
EX1G
SOU EXTENSION 1 GRANTED
04/10/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/10/2020
EXT1
SOU EXTENSION 1 FILED
04/08/2020
EEXT
SOU TEAS EXTENSION RECEIVED
04/08/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/08/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
10/22/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/27/2019
PUBO
PUBLISHED FOR OPPOSITION
08/27/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/07/2019
ALIE
ASSIGNED TO LIE
07/19/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/10/2019
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
12/21/2018
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
06/21/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
12/21/2017
GNSL
LETTER OF SUSPENSION E-MAILED
12/21/2017
CNSL
SUSPENSION LETTER WRITTEN
12/21/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/06/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/05/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/05/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/05/2017
GNRT
NON-FINAL ACTION E-MAILED
06/05/2017
CNRT
NON-FINAL ACTION WRITTEN
06/05/2017
DOCK
ASSIGNED TO EXAMINER
06/05/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/16/2017
NWAP
NEW APPLICATION ENTERED
03/14/2017
Continuous trademark protection
Get notified about every new filing that threatens PRECIGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.